Global Rivaroxaban Market Growth 2019-2024

  • ID:PD041116
  • February 2019
  • LPI (LP Information)
                          

DecisionDatabases.com offers Global Rivaroxaban Market Research Report with market statistics and future prospect for the year 2019-2024. This report explores historical data, market share, sales, consumption, revenue and market dynamic resulting in high quality and precise data. The future trend and outlook are analyzed and compiled with the help of industry experts. This report offers different segment analysis based on global, regional and country level along with key players with their revenue, sales, and strategic development. The data is gathered and analyzed  through primary and secondary research based on expert interviews, white papers, journals and various other sources.

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.

The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.

Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.

According to this study, over the next five years the Rivaroxaban market will register a 9.4% CAGR in terms of revenue, the global market size will reach US$ 10100 million by 2024, from US$ 5860 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rivaroxaban business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Rivaroxaban market by product type, application, key manufacturers and key regions and countries.

This study considers the Rivaroxaban value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

  •  2.5 mg
  •  10 mg
  •  15 mg
  •  20 mg
 
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
  •  Acute Coronary Syndrome (ACS)
  •  Venous Thromboembolism (VTE)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  •  Americas
  •  United States
  •  Canada
  •  Mexico
  •  Brazil
  •  APAC
  •  China
  •  Japan
  •  Korea
  •  Southeast Asia
  •  India
  •  Australia
  •  Europe
  •  Germany
  •  France
  •  UK
  •  Italy
  •  Russia
  •  Spain
  •  Middle East & Africa
  •  Egypt
  •  South Africa
  •  Israel
  •  Turkey
  •  GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  •  Bayer
  •  J&J
 
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  •  To study and analyze the global Rivaroxaban consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  •  To understand the structure of Rivaroxaban market by identifying its various subsegments.
  •  Focuses on the key global Rivaroxaban manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  •  To analyze the Rivaroxaban with respect to individual growth trends, future prospects, and their contribution to the total market.
  •  To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  •  To project the consumption of Rivaroxaban submarkets, with respect to key regions (along with their respective key countries).
  •  To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  •  To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
 
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rivaroxaban Consumption 2014-2024
2.1.2 Rivaroxaban Consumption CAGR by Region
2.2 Rivaroxaban Segment by Type
2.2.1 2.5 mg
2.2.2 10 mg
2.2.3 15 mg
2.2.4 20 mg
2.3 Rivaroxaban Consumption by Type
2.3.1 Global Rivaroxaban Consumption Market Share by Type (2014-2019)
2.3.2 Global Rivaroxaban Revenue and Market Share by Type (2014-2019)
2.3.3 Global Rivaroxaban Sale Price by Type (2014-2019)
2.4 Rivaroxaban Segment by Application
2.4.1 Acute Coronary Syndrome (ACS)
2.4.2 Venous Thromboembolism (VTE)
2.5 Rivaroxaban Consumption by Application
2.5.1 Global Rivaroxaban Consumption Market Share by Application (2014-2019)
2.5.2 Global Rivaroxaban Value and Market Share by Application (2014-2019)
2.5.3 Global Rivaroxaban Sale Price by Application (2014-2019)
 
3 Global Rivaroxaban by Players
3.1 Global Rivaroxaban Sales Market Share by Players
3.1.1 Global Rivaroxaban Sales by Players (2017-2019)
3.1.2 Global Rivaroxaban Sales Market Share by Players (2017-2019)
3.2 Global Rivaroxaban Revenue Market Share by Players
3.2.1 Global Rivaroxaban Revenue by Players (2017-2019)
3.2.2 Global Rivaroxaban Revenue Market Share by Players (2017-2019)
3.3 Global Rivaroxaban Sale Price by Players
3.4 Global Rivaroxaban Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Rivaroxaban Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Rivaroxaban Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
 
4 Rivaroxaban by Regions
4.1 Rivaroxaban by Regions
4.1.1 Global Rivaroxaban Consumption by Regions
4.1.2 Global Rivaroxaban Value by Regions
4.2 Americas Rivaroxaban Consumption Growth
4.3 APAC Rivaroxaban Consumption Growth
4.4 Europe Rivaroxaban Consumption Growth
4.5 Middle East & Africa Rivaroxaban Consumption Growth
 
5 Americas
5.1 Americas Rivaroxaban Consumption by Countries
5.1.1 Americas Rivaroxaban Consumption by Countries (2014-2019)
5.1.2 Americas Rivaroxaban Value by Countries (2014-2019)
5.2 Americas Rivaroxaban Consumption by Type
5.3 Americas Rivaroxaban Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
 
6 APAC
6.1 APAC Rivaroxaban Consumption by Countries
6.1.1 APAC Rivaroxaban Consumption by Countries (2014-2019)
6.1.2 APAC Rivaroxaban Value by Countries (2014-2019)
6.2 APAC Rivaroxaban Consumption by Type
6.3 APAC Rivaroxaban Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
 
7 Europe
7.1 Europe Rivaroxaban by Countries
7.1.1 Europe Rivaroxaban Consumption by Countries (2014-2019)
7.1.2 Europe Rivaroxaban Value by Countries (2014-2019)
7.2 Europe Rivaroxaban Consumption by Type
7.3 Europe Rivaroxaban Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
 
8 Middle East & Africa
8.1 Middle East & Africa Rivaroxaban by Countries
8.1.1 Middle East & Africa Rivaroxaban Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Rivaroxaban Value by Countries (2014-2019)
8.2 Middle East & Africa Rivaroxaban Consumption by Type
8.3 Middle East & Africa Rivaroxaban Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
 
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
 
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Rivaroxaban Distributors
10.3 Rivaroxaban Customer
 
11 Global Rivaroxaban Market Forecast
11.1 Global Rivaroxaban Consumption Forecast (2019-2024)
11.2 Global Rivaroxaban Forecast by Regions
11.2.1 Global Rivaroxaban Forecast by Regions (2019-2024)
11.2.2 Global Rivaroxaban Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Rivaroxaban Forecast by Type
11.8 Global Rivaroxaban Forecast by Application
 
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Details
12.1.2 Rivaroxaban Product Offered
12.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bayer News
12.2 J&J
12.2.1 Company Details
12.2.2 Rivaroxaban Product Offered
12.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 J&J News
 
13 Research Findings and Conclusion

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Report 2019-2025

The Global Tigecycline Market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This report  read more..


Global Caffeine Market Research Report 2017

The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure,  read more..


Global Rabies Vaccine Market Research Report 2017

The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Research Report 2019

The Global Radiopharmaceuticals market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..